Anna's Daybreak News

_{Just facts, you think for yourself}

Wednesday, 5:17 AM

November 27, 2024

Good morning news friend! Stay connected to the stories that shape our time, keeping pace with a world in motion. 📰🌟

Israel and Hezbollah's 60-Day Cease-Fire Agreement

Israel and Hezbollah agreed to a 60-day cease-fire after weeks of US-mediated talks. Polls show 37% of Israelis support the cease-fire, while 32% oppose it.

The cease-fire begins today at 4 AM local time. Both sides accepted the accord with Israel's security cabinet voting 10-1 in favor. President Joe Biden emphasized this agreement aims for a permanent cessation of hostilities.

Under the deal, Israel will withdraw its forces, while Lebanon will deploy 5,000 troops to secure its border. Biden highlighted that civilians on both sides could soon return to their communities.

However, Prime Minister Netanyahu warned of a strong response to any violations by Hezbollah. Meanwhile, Hamas now claims to be ready for a cease-fire too.

Source: Read More

Mexico's Response to Trump's Tariffs

Mexico’s President Claudia Sheinbaum emphasized that Trump's proposal for a 25% tariff would harm both economies. Mexico exports 80% of its goods to the US.

She warned of a potential tariff war that could damage joint ventures in the automotive industry, involving General Motors and Ford. In 2022, exports to Mexico comprised nearly 16% of all US.

Sheinbaum noted that illegal border crossings fell from December 2023 to November 2024, thanks to Mexico's own measures.

She also pointed out that the fentanyl crisis is driven by demand in the US and called for international cooperation to combat drug smuggling. She also outlined her country's ongoing steps to tackle illegal migration and drugs,

Source: Read More

GLP-1’s for Everyone?

President Biden introduced a proposal to have Medicare and Medicaid cover expensive weight-loss drugs. This plan could benefit millions of obese Americans. Drugs like Wegovy and Zepbound may soon be accessible.

The proposal could cost taxpayers about $35 billion over the next decade. Currently, around 3.5 million Medicare recipients and 4 million Medicaid recipients might qualify for these drugs.

However, research indicates as many as 28 million individuals on Medicaid may be obese. Under this proposal, only individuals with a body mass index of 30 or higher would receive coverage.

A monthly supply of Wegovy costs $1,300, and Zepbound costs $1,000. Robert F. Kennedy Jr. argues that the funds should instead support healthier food options and gym memberships.

Source: Read More

Thanksgiving Winter Storms

In the Sierra Nevada mountains, up to 3 feet of snow will fall. Maine, Vermont, New Hampshire, and parts of New York will experience freezing rain, causing risky driving conditions on Tuesday.

A cold front moves through the Midwest and South starting Wednesday. It will reach the East Coast by Thanksgiving Day, bringing rain and snow.

Travel is expected to reach pre-pandemic levels. Almost 80 million people will travel over 50 miles from Tuesday to Monday.

AAA projects that 71.7 million will drive, surpassing 2019 levels. Additionally, nearly 6 million are expected to fly, marking an 11% increase from 2019.

Source: Read More

SpaceX Takes On Mobile Connectivity

US regulators have approved SpaceX's plan to enhance T-Mobile's cellular network using Starlink satellites.

The Federal Communications Commission granted permission for SpaceX to offer mobile coverage to consumer phones. This service uses satellite connections to enhance traditional mobile networks.

SpaceX's partnership with T-Mobile uses 320 second-generation Starlink satellites with Direct to Cell technology. Initial tests show download speeds reaching up to 17 Mbps, with connectivity available indoors.

The launch will initially offer satellite-enabled text messaging, followed by voice and data services expected in 2025.

Source: Read More

PillBot Can See Inside Your Stomach

Endiatx introduced PillBot, a micro-robot designed to enhance gastrointestinal diagnostics. This capsule, about the size of a vitamin pill, wirelessly navigates the stomach and transmits live video, allowing remote physicians to conduct scans.

After patients drink water and swallow PillBot, doctors can control its movement via the internet. PillBot aims to replace invasive endoscopies, which often yield negative results in 80% of cases.

Key features include a 30-minute battery life and a low production cost of $35. This shift could save patients from sedation, hospital visits, and unnecessary costs.

Clinical trials are set to conclude in 2024, with FDA clearance anticipated in 2025 and a commercial launch in the U.S. by early 2026.

Source: Read More

“When a woman says about a man that he is intelligent, she often means handsome; when a man says about a woman that she is dumb, he always means attractive.”

Baked with love,

Anna Eisenberg ❤️